94 related articles for article (PubMed ID: 37283522)
1. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: A workshop report with focus on novel entities and a literature review including paediatric cases.
Saft L; Kvasnicka HM; Boudova L; Gianelli U; Lazzi S; Rozman M
Histopathology; 2023 Dec; 83(6):829-849. PubMed ID: 37551450
[TBL] [Abstract][Full Text] [Related]
2. T cell phenotype and lack of eosinophilia are not uncommon in extramedullary myeloid/lymphoid neoplasms with ETV6::FLT3 fusion: a case report and review of the literature.
Schoelinck J; Gervasoni J; Guillermin Y; Beillard E; Pissaloux D; Chassagne-Clement C
Virchows Arch; 2024 May; 484(5):853-857. PubMed ID: 37985498
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFCH).
Decamp M; Klein E; Godon C; Lestringant V; Roynard P; Theisen O; Jimenez-Pocquet M; Roche-Lestienne C; Bidet A; Veronese L
Curr Res Transl Med; 2023; 71(4):103424. PubMed ID: 38011761
[TBL] [Abstract][Full Text] [Related]
4. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
Shomali W; Gotlib J
Am J Hematol; 2024 May; 99(5):946-968. PubMed ID: 38551368
[TBL] [Abstract][Full Text] [Related]
5. Systemic mastocytosis: 2023 update on diagnosis and management in adults.
Costa A; Scalzulli E; Carmosino I; Capriata M; Ielo C; Masucci C; Passucci M; Martelli M; Breccia M
Expert Opin Emerg Drugs; 2023 Dec; 28(3):153-165. PubMed ID: 37256917
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Therapeutic Intervention of Hypereosinophilia in the Era of Molecular Diagnosis.
Nguyen L; Saha A; Kuykendall A; Zhang L
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611061
[TBL] [Abstract][Full Text] [Related]
7. [Guideline of the diagnosis and treatment of eosinophilic disorders (2024)].
Leukemia and Lymphoma Group, Chinese Society of Hematology, Chinese Medical Association
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):1-7. PubMed ID: 38527831
[TBL] [Abstract][Full Text] [Related]
8. A population-based study of chronic eosinophilic leukemia-not otherwise specified in the United States.
Ruan GJ; Smith CJ; Day C; Harmsen WS; Zblewski DL; Alkhateeb H; Begna K; Al-Kali A; Litzow MR; Hogan W; Gangat N; Patnaik MS; Pardanani A; Tefferi A; Go RS; Shah MV
Am J Hematol; 2020 Oct; 95(10):E257-E260. PubMed ID: 32533865
[No Abstract] [Full Text] [Related]
9. Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management.
Pardanani A
Am J Hematol; 2023 Jul; 98(7):1097-1116. PubMed ID: 37309222
[TBL] [Abstract][Full Text] [Related]
10. HES and EGPA: Two Sides of the Same Coin.
Khoury P; Akuthota P; Kwon N; Steinfeld J; Roufosse F
Mayo Clin Proc; 2023 Jul; 98(7):1054-1070. PubMed ID: 37419574
[TBL] [Abstract][Full Text] [Related]
11. Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm.
Tefferi A; Alkhateeb H; Gangat N
Blood Cancer J; 2023 Jul; 13(1):108. PubMed ID: 37460550
[TBL] [Abstract][Full Text] [Related]
12. Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights.
Iezza M; Cortesi S; Ottaviani E; Mancini M; Venturi C; Monaldi C; De Santis S; Testoni N; Soverini S; Rosti G; Cavo M; Castagnetti F
Cells; 2023 Jun; 12(13):. PubMed ID: 37443737
[TBL] [Abstract][Full Text] [Related]
13. Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management.
Tefferi A; Barbui T
Am J Hematol; 2023 Sep; 98(9):1465-1487. PubMed ID: 37357958
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management.
Garcia-Manero G
Am J Hematol; 2023 Aug; 98(8):1307-1325. PubMed ID: 37288607
[TBL] [Abstract][Full Text] [Related]
15. WHO or International Consensus Classification: Is the Difference Worth It?
Cree IA; Khoury JD
J Clin Oncol; 2023 Nov; 41(31):4937-4938. PubMed ID: 37467455
[No Abstract] [Full Text] [Related]
16. Cardiac Mechanics and Valvular and Vascular Abnormalities in Hypereosinophilic Syndrome.
Nemes A
J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592243
[TBL] [Abstract][Full Text] [Related]
17. Neutrophilic and eosinophilic dermatoses associated with hematological malignancy.
Maronese CA; Derlino F; Moltrasio C; Cattaneo D; Iurlo A; Marzano AV
Front Med (Lausanne); 2023; 10():1324258. PubMed ID: 38249974
[TBL] [Abstract][Full Text] [Related]
18. Case Report: A novel
Zhang Z; Zhu Y; Wang Z; Zeng Z; Wen L; Zhang L; Chen S
Front Oncol; 2023; 13():1276695. PubMed ID: 38023217
[TBL] [Abstract][Full Text] [Related]
19. The international consensus classification of eosinophilic disorders and systemic mastocytosis.
Wang SA; Orazi A; Gotlib J; Reiter A; Tzankov A; Hasserjian RP; Arber DA; Tefferi A
Am J Hematol; 2023 Aug; 98(8):1286-1306. PubMed ID: 37283522
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
